AssayIndex
Reports by quarter

Reports submitted in 2024-Q2 · page 8

First quarter of live submission. Median purity for the quarter is 99.08 % area, n=349. Read the 2024-Q2 state-of-the-index report →

349 records9 pagesmedian on this page 99.09 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2024-005179LL-37SSASSA-2403-V6258Nordanalyt2024-Q298.922.8198.6Supplier-supplied1MARGINAL
AX-2024-004191Kisspeptin-10WWBWWB-2311-T3203PeptideMeter2024-Q299.936.5197.4Supplier-supplied0PASS
AX-2024-005344TirzepatideSGNSGN-2401-K1375Medutest2024-Q298.084.06Laboratory-retained3FAIL
AX-2024-005175LL-37SSASSA-2403-V6258VendorInvestigate2024-Q297.682.54Buyer-sourced0PASS
AX-2024-005124SermorelinKPKP-2312-R4578Janoshik2024-Q299.256.7793.7Supplier-supplied0PASS
AX-2024-004869PT-141 (Bremelanotide)SWBSWB-2311-H6137Nordanalyt2024-Q299.253.93Supplier-supplied0PASS
AX-2024-004538SemaglutideJEEPJEEP-2401-R2856Janoshik2024-Q299.438.30Supplier-supplied0FAIL
AX-2024-005528SemaglutideBCHBCH-2401-C7932Nordanalyt2024-Q298.565.7188.8Supplier-supplied3MARGINAL
AX-2024-004307SermorelinQYBQYB-2404-W5163Medutest2024-Q298.753.3895.0Supplier-supplied0PASS
AX-2024-004267SemaglutideQYBQYB-2311-U4777Janoshik2024-Q299.063.46Supplier-supplied1MARGINAL
AX-2024-005223IGF-1 DES (1-3)SSASSA-2403-F6661Janoshik2024-Q298.513.7588.0Supplier-supplied1MARGINAL
AX-2024-005079SemaglutideMKMMKM-2403-C3618Janoshik2024-Q298.365.80106.2Supplier-supplied1MARGINAL
AX-2024-004469GHRP-6FGPFGP-2312-X1645Janoshik2024-Q299.844.46106.5Supplier-supplied1MARGINAL
AX-2024-004194Kisspeptin-10WWBWWB-2311-T3203Janoshik2024-Q299.866.4497.4Supplier-supplied1MARGINAL
AX-2024-005219IGF-1 DES (1-3)SSASSA-2403-F6661Janoshik2024-Q299.933.85Supplier-supplied1MARGINAL
AX-2024-005218IGF-1 DES (1-3)SSASSA-2403-F6661Janoshik2024-Q299.004.0588.0Supplier-supplied1MARGINAL
AX-2024-004606Melanotan IITFCTFC-2401-J4881Kestrel2024-Q299.933.5389.6Supplier-supplied2MARGINAL
AX-2024-005460SemaglutideBCHBCH-2405-U6438Janoshik2024-Q297.543.83Buyer-sourced3FAIL
AX-2024-004931BPC-157ERPERP-2402-D7200Janoshik2024-Q299.666.62101.5Supplier-supplied1MARGINAL
AX-2024-004894TirzepatideERPERP-2401-D6074Medutest2024-Q298.653.67102.2Supplier-supplied2FAIL
AX-2024-004889TB-500ERPERP-2401-K6373Janoshik2024-Q299.652.73106.8Supplier-supplied2MARGINAL
AX-2024-004296Melanotan IIQYBQYB-2402-P5428Janoshik2024-Q299.875.6791.7Supplier-supplied1MARGINAL
AX-2024-005384PinealonCPCCPC-2403-R3097Medutest2024-Q299.198.12Buyer-sourced1FAIL
AX-2024-005270TirzepatideSSASSA-2312-V7746Nordanalyt2024-Q298.075.5299.4Supplier-supplied1MARGINAL
AX-2024-004927BPC-157ERPERP-2402-D7200Kestrel2024-Q299.276.59Buyer-sourced1MARGINAL
AX-2024-005470SemaglutideBCHBCH-2405-U6438VendorInvestigate2024-Q297.554.01Buyer-sourced2MARGINAL
AX-2024-005388PinealonCPCCPC-2403-R3097PeptideMeter2024-Q299.778.00Supplier-supplied1FAIL
AX-2024-004600Melanotan IITFCTFC-2401-J4881PeptideMeter2024-Q299.183.69Supplier-supplied1MARGINAL
AX-2024-005275BPC-157SSASSA-2401-E8185Kestrel2024-Q299.614.6892.3Supplier-supplied1MARGINAL
AX-2024-005176LL-37SSASSA-2403-V6258Medutest2024-Q298.821.96Supplier-supplied1MARGINAL
AX-2024-005077SemaglutideMKMMKM-2403-C3618Janoshik2024-Q299.106.01102.5Supplier-supplied0PASS
AX-2024-004928BPC-157ERPERP-2402-D7200Nordanalyt2024-Q298.976.65Buyer-sourced1MARGINAL
AX-2024-004891TB-500ERPERP-2401-K6373Janoshik2024-Q299.083.60Supplier-supplied2MARGINAL
AX-2024-004607Melanotan IITFCTFC-2401-J4881Janoshik2024-Q298.653.5694.5Buyer-sourced1MARGINAL
AX-2024-005471SemaglutideBCHBCH-2405-U6438PeptideMeter2024-Q298.084.45Supplier-supplied2MARGINAL
AX-2024-005413SemaxWXTWXT-2402-W3946Medutest2024-Q298.206.68Supplier-supplied0FAIL
AX-2024-005129SermorelinKPKP-2312-R4578Nordanalyt2024-Q299.296.49Supplier-supplied0PASS
AX-2024-004893TirzepatideERPERP-2401-D6074Janoshik2024-Q299.314.01100.7Supplier-supplied1MARGINAL
AX-2024-004724MK-677 (Ibutamoren mesylate)HomopeptideHOMO-2401-J8536Janoshik2024-Q299.664.95Supplier-supplied1FAIL
AX-2024-005271TirzepatideSSASSA-2312-V7746Janoshik2024-Q298.045.9488.8Supplier-supplied2MARGINAL